AssurX provides solutions for compliance with 21 CFR 820.30, ensuring medical device manufacturers meet FDA’s design control requirements. Our platform enhances design processes, streamlines documentation, and supports operational excellence to maintain compliance.
19
01, 2023
An Overview of the FDA Draft of CSA Guidance for Quality Systems
In September 2022, the (FDA) released draft computer systems assurance (CSA) gui [...]
